233
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

A Rare Case of Neuralgic Amyotrophy Associated with Brucella Infection

, , , &
Pages 1145-1151 | Received 04 Dec 2022, Accepted 27 Jan 2023, Published online: 23 Feb 2023

References

  • Ijspeert J, Janssen RMJ, van Alfen N. Neuralgic amyotrophy. Curr Opin Neurol. 2021;34(5):605–612. doi:10.1097/WCO.0000000000000968
  • van Alfen N. Clinical and pathophysiological concepts of neuralgic amyotrophy. Nat Rev Neurol. 2011;7(6):315–322. doi:10.1038/nrneurol.2011.62
  • van Alfen N, van Engelen BGM. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006;129:438–450. doi:10.1093/brain/awh722
  • Stek CJ, van Eijk JJJ, Jacobs BC, et al. Neuralgic amyotrophy associated with Bartonella henselae infection. J Neurol Neurosurg Psychiatry. 2011;82(6):707–708. doi:10.1136/jnnp.2009.191940
  • Ismail II, Abdelnabi EA, Al-Hashel JY, et al. Neuralgic amyotrophy associated with COVID-19 infection: a case report and review of the literature. Neurol Sci. 2021;42(6):2161–2165. doi:10.1007/s10072-021-05197-z
  • Bahemuka M, Shemena AR, Panayiotopoulos CP, et al. Neurological syndromes of brucellosis. J Neurol Neurosurg Psychiatry. 1988;51(8):1017–1021. doi:10.1136/jnnp.51.8.1017
  • Ara JR, Oliveros A. Neuralgic amyotrophy of the shoulder associated with systemic brucellosis. Med Clin. 1992;99(20):794–795.
  • Yagupsky P, Morata P, Colmenero JD. Laboratory diagnosis of human brucellosis. Clin Microbiol Rev. 2020;33(1):e00073.
  • Buzgan T, Karahocagil MK, Irmak H, et al. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 2010;14(6):E469–E478. doi:10.1016/j.ijid.2009.06.031
  • van Eijk JJJ, van Alfen N, Berrevoets M, et al. Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy: an observational study. J Neurol Neurosurg Psychiatry. 2009;80(10):1120–1124. doi:10.1136/jnnp.2008.163386
  • Zheng R, Xie S, Lu X, et al. A systematic review and meta-analysis of epidemiology and clinical manifestations of human brucellosis in China. Biomed Res Int. 2018;2018:1–10. doi:10.1155/2018/5712920
  • Shanina E, Liao B, Smith RG. Brachial plexopathies: update on treatment. Curr Treat Options Neurol. 2019;21(5):5. doi:10.1007/s11940-019-0562-5
  • Stutz CM. Neuralgic amyotrophy: parsonage-turner syndrome. J Hand Surg Am. 2010;35A(12):2104–2106. doi:10.1016/j.jhsa.2010.09.010
  • Yang LJS. Neonatal brachial plexus palsy-Management and prognostic factors. Semin Perinatol. 2014;38(4):222–234. doi:10.1053/j.semperi.2014.04.009
  • Kim TU, Chang MC. Neuralgic amyotrophy: an underrecognized entity. J Int Med Res. 2021;49(4):030006052110065. doi:10.1177/03000605211006542
  • Seror P. Neuralgic amyotrophy an update. Joint Bone Spine. 2017;84(2):153–158. doi:10.1016/j.jbspin.2016.03.005
  • Sneag DB, Saltzman EB, Meister DW, et al. MRI Bullseye sign: an indicator of peripheral nerve constriction in parsonage-turner syndrome. Muscle Nerve. 2017;56(1):99–106. doi:10.1002/mus.25480
  • Lee JS, Kim YT, Kim JS, et al. The clinical manifestations and outcomes of neuralgic amyotrophy. Neurol Asia. 2017;22(1):9–13.
  • Ang CW, Jacobs BC, Laman JD. The Guillain-Barre syndrome: a true case of molecular mimicry. Trends Immunol. 2004;25(2):61–66. doi:10.1016/j.it.2003.12.004
  • Watanabe K, Kim S, Nishiguchi M, et al. Brucella melitensis infection associated with Guillain-Barré syndrome through molecular mimicry of host structures. FEMS Immunol Med Microbiol. 2005;45(2):121–127. doi:10.1016/j.femsim.2005.03.001
  • Suarez GA, Giannini C, Bosch EP, et al. Immune brachial plexus neuropathy: suggestive evidence for an inflammatory-immune pathogenesis. Neurology. 1996;46(2):559–561. doi:10.1212/WNL.46.2.559
  • Skendros P, Pappas G, Boura P. Cell-mediated immunity in human brucellosis. Microbes Infect. 2011;13(2):134–142. doi:10.1016/j.micinf.2010.10.015
  • Johnson NE, Petraglia AL, Huang JH, et al. Rapid resolution of severe neuralgic amyotrophy after treatment with corticosteroids and intravenous immunoglobulin. Muscle Nerve. 2011;44(2):304–305. doi:10.1002/mus.22100
  • Lieba-Samal D, Jengojan S, Kasprian G, et al. Neuroimaging of classic neuralgic amyotrophy. Muscle Nerve. 2016;54(6):1079–1085. doi:10.1002/mus.25147
  • Gstoettner C, Mayer JA, Rassam S, et al. Neuralgic amyotrophy: a paradigm shift in diagnosis and treatment. J Neurol Neurosurg Psychiatry. 2020;91(8):879–888. doi:10.1136/jnnp-2020-323164